

Keurig Dr Pepper vs FEMSA
Keurig Dr Pepper dominates single-serve coffee and cold beverages in North America while FEMSA operates a sprawling Latin American conglomerate anchored by the world's largest Coca-Cola bottler and a massive convenience store chain. Both companies run distribution-heavy models where scale and logistics efficiency determine who wins on margins. The Keurig Dr Pepper vs FEMSA comparison explores how each company leverages its distribution infrastructure, pricing power, and geographic footprint to compound earnings.
Keurig Dr Pepper dominates single-serve coffee and cold beverages in North America while FEMSA operates a sprawling Latin American conglomerate anchored by the world's largest Coca-Cola bottler and a ...
Why It's Moving

KDP Sparks Optimism with Q1 Earnings Beat and Robust 2026 Sales Outlook
- JPMorgan raised its outlook on April 24, spotlighting undervaluation amid strong beverage demand despite margin pressures.
- Barclays lifted price target to $30 on April 27, reflecting confidence in ongoing U.S. refreshment momentum.
- Q1 EPS hit $0.39 versus $0.37 expected, with analysts upgrading ratings to underscore acquisition synergies and growth potential.

Analysts Uplift FMX Targets Amid Mixed Buy-Hold Signals
- JPMorgan Chase hiked its FMX target to $117 from $98 on April 20, maintaining a neutral stance but highlighting improved fundamentals.
- UBS kept its Buy rating and boosted the target to $122, underscoring strong regional sales momentum.
- Goldman Sachs and others lifted targets to $128 and $122 respectively, pointing to FMX's competitive edge in the beverage sector.

KDP Sparks Optimism with Q1 Earnings Beat and Robust 2026 Sales Outlook
- JPMorgan raised its outlook on April 24, spotlighting undervaluation amid strong beverage demand despite margin pressures.
- Barclays lifted price target to $30 on April 27, reflecting confidence in ongoing U.S. refreshment momentum.
- Q1 EPS hit $0.39 versus $0.37 expected, with analysts upgrading ratings to underscore acquisition synergies and growth potential.

Analysts Uplift FMX Targets Amid Mixed Buy-Hold Signals
- JPMorgan Chase hiked its FMX target to $117 from $98 on April 20, maintaining a neutral stance but highlighting improved fundamentals.
- UBS kept its Buy rating and boosted the target to $122, underscoring strong regional sales momentum.
- Goldman Sachs and others lifted targets to $128 and $122 respectively, pointing to FMX's competitive edge in the beverage sector.
Investment Analysis
Pros
- Strong revenue growth with Q3 2025 net sales up 10.7% year-over-year and a raised full-year net sales growth outlook.
- Robust earnings performance highlighted by solid adjusted EPS growth and improving free cash flow, supporting financial health.
- Strategic acquisition of JDE Peet’s aims to boost future growth and enable a planned split into two focused public companies.
Considerations
- Integration risks and execution complexity linked to the $18 billion JDE Peet’s acquisition and forthcoming corporate split.
- Ongoing inflationary pressures on green coffee and brewing equipment raise cost challenges, especially in the coffee segment.
- Potential tariff-driven cost inflation and commodity price volatility may temper profitability and synergy realisation.

FEMSA
FMX
Pros
- Strong competitive position as a leading beverage and retail conglomerate in Mexico and parts of Latin America.
- Reasonable valuation metrics with price/earnings ratios indicating a balance between growth expectations and financial strength.
- Diverse business segments including beverages and convenience retail, providing multiple growth avenues and revenue streams.
Considerations
- Relatively low quick ratio suggests limited short-term liquidity, which may constrain operational flexibility under stress.
- Exposure to Mexican economy and currency risks could impact financial performance amid macroeconomic volatility.
- Potential sensitivity to regulatory changes in alcohol and beverage markets in key operating regions introduces compliance risks.
Keurig Dr Pepper (KDP) Next Earnings Date
Keurig Dr Pepper (KDP) reported its Q1 2026 earnings on April 23, 2026, covering the quarter ended March 31, 2026. The next earnings release, for Q2 2026, is expected on July 23, 2026, consistent with the company's historical quarterly pattern. This date aligns with prior releases such as Q2 2025 on July 24.
FEMSA (FMX) Next Earnings Date
Fomento Economico Mexicano (FMX) is scheduled to release its Q1 2026 earnings results before market open on Thursday, April 30, 2026. The company will hold a conference call at 11:00 AM ET following the announcement. Analysts expect the company to report earnings per share of $0.8060 and revenue of $11.4184 billion for the quarter.
Keurig Dr Pepper (KDP) Next Earnings Date
Keurig Dr Pepper (KDP) reported its Q1 2026 earnings on April 23, 2026, covering the quarter ended March 31, 2026. The next earnings release, for Q2 2026, is expected on July 23, 2026, consistent with the company's historical quarterly pattern. This date aligns with prior releases such as Q2 2025 on July 24.
FEMSA (FMX) Next Earnings Date
Fomento Economico Mexicano (FMX) is scheduled to release its Q1 2026 earnings results before market open on Thursday, April 30, 2026. The company will hold a conference call at 11:00 AM ET following the announcement. Analysts expect the company to report earnings per share of $0.8060 and revenue of $11.4184 billion for the quarter.
Buy KDP or FMX in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


